- Home
- ACIU vs SKIN Comparison
ACIU vs SKIN Comparison
Compare ACIU & SKIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ACIU | SKIN |
|---|---|---|
| Founded | 2003 | 1997 |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Package Goods/Cosmetics |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 213.3M | 202.7M |
| IPO Year | 2016 | N/A |
Fundamental Metrics
Financial Performance| Metric | ACIU | SKIN |
|---|---|---|
| Price | $3.04 | $1.52 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 3 |
| Target Price | ★ $10.00 | $2.42 |
| AVG Volume (30 Days) | ★ 1.4M | 758.6K |
| Earning Date | 11-04-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $5,482,957.00 | ★ $301,917,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $738.95 | $4.30 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.43 | $0.78 |
| 52 Week High | $4.00 | $2.69 |
Technical Indicators
Market Signals| Indicator | ACIU | SKIN |
|---|---|---|
| Relative Strength Index (RSI) | 49.88 | 55.59 |
| Support Level | $2.54 | $1.33 |
| Resistance Level | $3.45 | $1.57 |
| Average True Range (ATR) | 0.30 | 0.12 |
| MACD | 0.05 | 0.00 |
| Stochastic Oscillator | 38.10 | 59.37 |
Price Performance
Historical ComparisonAbout ACIU AC Immune SA
AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses mostly of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.
About SKIN The Beauty Health Company
The Beauty Health Co is a category-creating beauty health company that along with its subsidiaries designs, develops, manufactures, markets and sells esthetic technologies and products. The company's brand portfolio includes Hydrafacial, SkinStylus, and Keravive, offering Syndeo device, SkinStylus SteriLock Microsystem, Keravive Peptide Solution and other products.